Transcriptional activation of ENPP1 by osterix in osteoblasts and osteocytes.

Transcriptional activation of ENPP1 by osterix in osteoblasts and osteocytes.
Eur Cell Mater. 2018 Jul 25;36:1-14
Authors: Gao MM, Su QN, Liang TZ, Ma JX, Liang TZ, Stoddart MJ, Richards RG, Zhou ZY, Zou NX
Abstract
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is the main source of extracellular pyrophosphate. Along with tissue-nonspecific alkaline phosphatase (TNAP), ENPP1 plays an important role in balancing bone mineralisation. Although well established in pre-osteoblasts, the regulating mechanisms of ENPP1 in osteoblasts and osteocytes remain largely unknown. Using bioinformatic methods, osterix (Osx), an essential transcription factor in osteoblast differentiation and osteocyte function, was found to have five predicted binding sites on the ENPP1 promoter. ENPP1 and Osx showed a similar expression profile both in vitro and in vivo. Over-expression of Osx in MC3T3-E1 and MLO-Y4 cells significantly up-regulated the expression of ENPP1 (p < 0.05). The consensus Sp1 sequences, located in the proximal ENPP1 promoter, were identified as Osx-regulating sites using promoter truncation experiments and chromatin immunoprecipitation (ChIP) assays. The p38-mitogen-activated protein kinase (MAPK) signalling pathway was demonstrated to be responsible for ENPP1 promoter activation by Osx. Runt-related transcription factor 2 (Runx2) was confirmed to have synergistic effects with Osx in activating ENPP1 promoter. Taken together,...

Source: European Cells and Materials - July 28, 2018 Category: Cytology Tags: Eur Cell Mater Source Type: research